Re: Don't forget the taxman on such a transaction
They will drag the time lines, increase bonus & salaries....add additional head count, open new centers in high rent districts and drive the burn rate to unbelievable heights...........wait... my bad thats what they are doing currently. Any way you look at it if we sell Etrasimod there will be nothing in it for shareholders other than a small increase in share value...cash is worthless to Wall Street. The BOD should be separated from the management team and the company should be sold in due time. We seen what happened at the end of the line with Belviq.....We're an R&D company with great science paid for by shareholders and fleeced by the management team. They do not respect shareholders. Proprietary information concerns me due to the ARNA management team serving on various boards through out biotech. This company has the guts to be SOLD right now before the BOD field dresses us.